Custo de Mercadoria Vendida Alterar Data
AstraZeneca USD -204M 3.48B 2026-03
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.08B 214.82M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Qiagen NV USD 217.43M 29.65M 2025-12
UCB EUR 1.07B 146M 2025-12